192 related articles for article (PubMed ID: 38225969)
1. Modulation of Cytosolic Phospholipase A2 as a Potential Therapeutic Strategy for Alzheimer's Disease.
André S; Verteneuil S; Ris L; Kahvecioglu ZC; Nonclercq D; De Winter J; Vander Elst L; Laurent S; Muller RN; Burtea C
J Alzheimers Dis Rep; 2023; 7(1):1395-1426. PubMed ID: 38225969
[TBL] [Abstract][Full Text] [Related]
2. Amyloid beta enhances cytosolic phospholipase A2 level and arachidonic acid release via nitric oxide in APP-transfected PC12 cells.
Chalimoniuk M; Stolecka A; Cakała M; Hauptmann S; Schulz K; Lipka U; Leuner K; Eckert A; Muller WE; Strosznajder JB
Acta Biochim Pol; 2007; 54(3):611-23. PubMed ID: 17713604
[TBL] [Abstract][Full Text] [Related]
3. The role of cytosolic phospholipase A2 α in amyloid precursor protein induction by amyloid beta1-42 : implication for neurodegeneration.
Sagy-Bross C; Kasianov K; Solomonov Y; Braiman A; Friedman A; Hadad N; Levy R
J Neurochem; 2015 Mar; 132(5):559-71. PubMed ID: 25533654
[TBL] [Abstract][Full Text] [Related]
4. 6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease.
Zueva IV; Semenov VE; Mukhamedyarov MA; Lushchekina SV; Kharlamova AD; Petukhova EO; Mikhailov AS; Podyachev SN; Saifina LF; Petrov KA; Minnekhanova OA; Zobov VV; Nikolsky EE; Masson P; Reznik VS
Int J Risk Saf Med; 2015; 27 Suppl 1():S69-71. PubMed ID: 26639718
[TBL] [Abstract][Full Text] [Related]
5. Oligomeric amyloid-beta induces MAPK-mediated activation of brain cytosolic and calcium-independent phospholipase A
Palavicini JP; Wang C; Chen L; Hosang K; Wang J; Tomiyama T; Mori H; Han X
Acta Neuropathol Commun; 2017 Jul; 5(1):56. PubMed ID: 28750656
[TBL] [Abstract][Full Text] [Related]
6. Calcium-dependent cytosolic phospholipase A
Wang S; Li B; Solomon V; Fonteh A; Rapoport SI; Bennett DA; Arvanitakis Z; Chui HC; Miller C; Sullivan PM; Wang HY; Yassine HN
Mol Neurodegener; 2021 Apr; 16(1):26. PubMed ID: 33863362
[TBL] [Abstract][Full Text] [Related]
7. Cytosolic phospholipase A2 (cPLA2) immunoreactivity is elevated in Alzheimer's disease brain.
Stephenson DT; Lemere CA; Selkoe DJ; Clemens JA
Neurobiol Dis; 1996 Feb; 3(1):51-63. PubMed ID: 9173912
[TBL] [Abstract][Full Text] [Related]
8. Human group V phospholipase A2 induces group IVA phospholipase A2-independent cysteinyl leukotriene synthesis in human eosinophils.
Muñoz NM; Kim YJ; Meliton AY; Kim KP; Han SK; Boetticher E; O'Leary E; Myou S; Zhu X; Bonventre JV; Leff AR; Cho W
J Biol Chem; 2003 Oct; 278(40):38813-20. PubMed ID: 12796497
[TBL] [Abstract][Full Text] [Related]
9. Cytosolic Phospholipase A
Teng T; Dong L; Ridgley DM; Ghura S; Tobin MK; Sun GY; LaDu MJ; Lee JC
Mol Neurobiol; 2019 May; 56(5):3222-3234. PubMed ID: 30112630
[TBL] [Abstract][Full Text] [Related]
10. Secretory phospholipase A2 receptor-mediated activation of cytosolic phospholipase A2 in murine bone marrow-derived mast cells.
Fonteh AN; Atsumi G; LaPorte T; Chilton FH
J Immunol; 2000 Sep; 165(5):2773-82. PubMed ID: 10946309
[TBL] [Abstract][Full Text] [Related]
11. Involvement of cytosolic phospholipase A2 and secretory phospholipase A2 in arachidonic acid release from human neutrophils.
Marshall J; Krump E; Lindsay T; Downey G; Ford DA; Zhu P; Walker P; Rubin B
J Immunol; 2000 Feb; 164(4):2084-91. PubMed ID: 10657662
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of cytosolic Phospholipase A2 prevents prion peptide-induced neuronal damage and co-localisation with Beta III Tubulin.
Last V; Williams A; Werling D
BMC Neurosci; 2012 Aug; 13():106. PubMed ID: 22928663
[TBL] [Abstract][Full Text] [Related]
13. Heterozygous knockout of cytosolic phospholipase A
Qu B; Gong Y; Gill JM; Kenney K; Diaz-Arrastia R
Brain Res; 2017 Sep; 1670():248-252. PubMed ID: 28648388
[TBL] [Abstract][Full Text] [Related]
14. Cytosolic phospholipase A2 mediates neuronal apoptosis induced by soluble oligomers of the amyloid-beta peptide.
Kriem B; Sponne I; Fifre A; Malaplate-Armand C; Lozac'h-Pillot K; Koziel V; Yen-Potin FT; Bihain B; Oster T; Olivier JL; Pillot T
FASEB J; 2005 Jan; 19(1):85-7. PubMed ID: 15486059
[TBL] [Abstract][Full Text] [Related]
15. Blocking the Interaction between EphB2 and ADDLs by a Small Peptide Rescues Impaired Synaptic Plasticity and Memory Deficits in a Mouse Model of Alzheimer's Disease.
Shi XD; Sun K; Hu R; Liu XY; Hu QM; Sun XY; Yao B; Sun N; Hao JR; Wei P; Han Y; Gao C
J Neurosci; 2016 Nov; 36(47):11959-11973. PubMed ID: 27881781
[TBL] [Abstract][Full Text] [Related]
16. Calcium-dependent cytosolic phospholipase A
Wang S; Li B; Solomon V; Fonteh A; Rapoport SI; Bennett DA; Arvanitakis Z; Chui HC; Sullivan PM; Yassine HN
Mol Neurodegener; 2022 Jun; 17(1):42. PubMed ID: 35705959
[TBL] [Abstract][Full Text] [Related]
17. Extracellular calcium regulates HeLa cell morphology during adhesion to gelatin: role of translocation and phosphorylation of cytosolic phospholipase A2.
Crawford JR; Jacobson BS
Mol Biol Cell; 1998 Dec; 9(12):3429-43. PubMed ID: 9843579
[TBL] [Abstract][Full Text] [Related]
18. Spinal phospholipase A2 in inflammatory hyperalgesia: role of group IVA cPLA2.
Lucas KK; Svensson CI; Hua XY; Yaksh TL; Dennis EA
Br J Pharmacol; 2005 Apr; 144(7):940-52. PubMed ID: 15685208
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus E3-10.4K/14.5K protein complex inhibits tumor necrosis factor-induced translocation of cytosolic phospholipase A2 to membranes.
Dimitrov T; Krajcsi P; Hermiston TW; Tollefson AE; Hannink M; Wold WS
J Virol; 1997 Apr; 71(4):2830-7. PubMed ID: 9060638
[TBL] [Abstract][Full Text] [Related]
20. Role of phosphorylation sites and the C2 domain in regulation of cytosolic phospholipase A2.
Gijón MA; Spencer DM; Kaiser AL; Leslie CC
J Cell Biol; 1999 Jun; 145(6):1219-32. PubMed ID: 10366595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
